Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples

Figure 2

PFS and OS of 45 OC patients by the level of 6 deregulated miRNAs. A-B, The PFS and OS in patients with higher miR-9 level are significantly longer than lower miR-9, P=0.0267 and 0.021. C-D, The PFS and OS in patients with higher miR-155 level are longer than lower miR-155, but not significantly, P=0.289 and 0.060. E, The PFS in patients with higher miR-640 level are longer than lower miR-640, but not significantly, P=0.148. F, The OS in patients with higher miR-640 level are significantly longer than lower miR-9, P=0.043. G-L, The PFS in patients with higher miR-320a, 22 and 129-5p level are shorter than lower miRNAs, but not significantly, P=0.055, 0.175 and 0.717. The OS in patients with higher miR-320a, 22 and 129-5p are no difference compared with lower miR-320a, 22 and 129-5p, P= 0.465, 0.550 and 0.646 in turns. MST, mean survival time in months.

Back to article page